Desensitization of Renal Transplant Candidates

Completed · Phase 1

Conditions studied: End Stage Renal Disease, Kidney Transplantation

In brief

Trial of the use of Myfortic to reduce anti-HLA alloantibody in patients waiting for renal transplantation.

Key facts

Study ID

NCT00298883

Run by

University of Florida

People needed

9

Starts

2006-02-01

Expected to finish

2008-12-01

Last updated by the study team

2012-07-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients on the deceased donor kidney transplant waiting list with panel reactive antibodies >50% and living donor waiting list patients who have a history of a positive crossmatch (donor-specific antibodies) will be eligible for the study.

You may not qualify if…

• Any subjects not meeting the Inclusion Criteria
• Subjects unable to attend weekly clinic visits for six weeks
• Inability to tolerate Myfortic

Where it is running

• University of Florida — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.